Delivery Order SPE2DX15D9113-SPE2DX24F7BPH
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $10,634.97 contract is for the delivery of Micardis HCT 80-25 mg tablet units to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999 through...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,906.39 contract is for the delivery of Micardis HCT 40-12.5 mg tablets to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $2,762.90, is for the delivery of Micardis HCT 80-25 mg tablet units to support the recurring medical supply needs of military health facilities. The contract has a completion date of October 27, 2022 and does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a...
- This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The award, valued at $1,548.35, is for the provision of pharmaceutical products and medical supplies to support U.S. military healthcare facilities. The delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which allows the...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $5,764.80, is for the delivery of MICARDIS HCT 80-25 MG TABLET UD 30S to fulfill the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The $27,540.09 contract is for the delivery of pharmaceutical products to support military health facilities globally. It is a task order under DMS Pharmaceutical Group's larger $4,999,999 indefinite delivery contract with DLA for a broad range of branded and generic medications, biologics, and other medical supplies. The award has no...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, under the SPE2DB program. The $2,460.12 contract is for the delivery of Micardis HCT 40-12.5 mg tablets to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business, to provide a wide range of pharmaceutical products to military health facilities. The contract has a ceiling value of $2,960.00 and an ultimate completion date of April 25, 2024. It is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Vehicle (IDV) contract SPE2DB with DLA, valued at up to $4,999,999...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of various pharmaceutical products and medical supplies. The contract has a ceiling value of $1,304.67 and a completion date of May 22, 2024. This order was issued under DMS Pharmaceutical's existing indefinite delivery contract (IDC) with DLA, valued at up to $499,999,999, which supports the recurring medical supply needs of...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, under the DLA's Medical Supply Chain program. The contract, valued at $3,247.96, is for the supply of various pharmaceutical products, including prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of U.S. military health facilities. The award...
- SPE2DX15D9113Indefinite Delivery Contract
- SPE2DX15D9113-SPE2DX24F7BPHDelivery Order
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a range of pharmaceutical products to the U.S. military. The contract has no set-aside designation and has a ceiling value of $1,201.00. It supports the recurring medical supply needs of military health facilities through the DLA's Single-Award Pharmaceutical Prime Vendor program (SPE2DB). DMS Pharmaceutical Group Inc. holds a separate $4,999,999 indefinite delivery contract with DLA for a broad array of pharmaceutical items, including medications, biologics, and medical supplies. This delivery order contract appears to be one of many issued under that larger DLA vehicle to enable DMS Pharmaceutical Group to deliver Micardis HCT 80-25 mg tablets to military medical facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 3/11/24 |